Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy
A. Sun , L.D. Durocher-Allen , P.M. Ellis , Y.C. Ung
Clinical Oncology 30 ( 10) 658 -666
5
2018
A comparison of patient knowledge of clinical trials and trialist priorities
P. Cameron , G.R. Pond , R.Y. Xu , P.M. Ellis
Current Oncology 20 ( 3) 193 -205
21
2013
Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases.
A. Ali , J.R. Goffin , A. Arnold , P.M. Ellis
Current Oncology 20 ( 4) 300 -306
74
2013
Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?
R. VanderMeer , S. Chambers , A. Van Dam , J.C. Cutz
Current Oncology 22 ( 4) 272 -278
7
2015
Implementing low-dose computed tomography screening for lung cancer in Canada: implications of alternative at-risk populations, screening frequency, and duration
W.K. Evans , W.M. Flanagan , A.B. Miller , J.R. Goffin
Current Oncology 23 ( 3) 179 -187
4
2016
Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment
P.O. Chappuis , E. Donato , J.R. Goffin , N. Wong
Annals of Oncology 16 ( 5) 735 -742
50
2005
The difference between study recommendations, stated policy, and actual practice in a clinical trial
J.R. Goffin , C. Savage , D. Tu , L. Shepherd
Annals of Oncology 15 ( 8) 1267 -1273
2
2004
Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy
D. Hao , P.M. Ellis , S.A. Laurie , R.A. Juergens
Annals of Oncology 30
2019
Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer
J R Goffin , O Straume , P O Chappuis , J-S Brunet
British Journal of Cancer 89 ( 6) 1031 -1034
44
2003
P1. 15-10 Chronic Obstructive Pulmonary Disease Patients Receiving Immunotherapy for Lung Cancer: A Population-Based Study in Canada
SWSS Chan , GR Pond , JR Goffin
Journal of Thoracic Oncology 17 ( 9) S124 -S124
2022
BRCA1 germ-line mutation status, distinctive cell cycle proteins expression and outcome after breast cancer.
PO Chappuis , E Donato , JR Goffin , N Wong
AMERICAN JOURNAL OF HUMAN GENETICS 73 ( 5) 231 -231
2003
Use of Bisphosphonates in Breast Cancer Metastatic to Bone at a Regional Cancer Centre
SK Dhesy-Thind , JR Goffin , L Reyno , PP Major
BREAST CANCER RESEARCH AND TREATMENT 64 ( 1) 361 -361
2000
Perspective on the National Comprehensive Cancer Network's clinical practice guidelines for smoking cessation. J Oncol Pract. 2016; 12 (1): 55–58. doi: 10.1200
JS Ostroff , JR Goffin , FR Khuri , GW Warren
JOP
3
2015
Resource Utilization in the Last Three Months of Life by Lung Cancer Patients in the Hamilton-Niagara-Haldimand-Brant Local Health Integration Network (Lhin)
Lorraine Martelli-Reid , Sally Hapke , Marissa Slaven , Susan Schiff
Journal of Thoracic Oncology 8
2013
Prognostic importance of glomeruloid microvascular proliferation indicates an aggressive angiogenic phenotype in human cancers.
Helga B. Salvesen , Lars A. Akslen , Oddbjørn Straume , Svein A. Haukaas
Cancer Research 62 ( 23) 6808 -6811
125
2002
Performance of the cancer risk management model lung cancer screening module.
Michael C. Wolfson , Natalie R. Fitzgerald , John R. Goffin , Anthony B. Miller
Health Reports 26 ( 5) 11
14
2015
Risk Perception Among a Lung Cancer Screening Population.
Jane Turner , Gregory R Pond , Alain Tremblay , Michael Johnston
Chest
2021
Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system.
Sophie Corriveau , John R. Goffin , Gregory R. Pond , Grace H. Tang
PLOS ONE 16 ( 5)
2021
A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy – Canadian Cancer Trials Group IND 211.
Donald Morris , Dongsheng Tu , Mustapha Ali Tehfe , Garth Andrew Nicholas
Journal of Clinical Oncology 34
3
2016
A meta-analysis of trials of etoposide plus platinum agent versus irinotecan/topotecan plus platinum agent in first-line therapy of extensive stage small cell lung cancer (ES SCLC).
Peter Michael Ellis , Lisa Durocher-Allen , Emily Vella , Alexander Sun
Journal of Clinical Oncology 35 ( 15_suppl) e20019 -e20019
2017